US

Uday Singh

Active Director Director DIN 01982715
DIN 01982715 First appointment Apr 2007 Primary industry E-Commerce
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2007
Shareholding value •••• Premium profile

About Uday Singh

Data last updated:

Uday Singh is a Director at Maharshi Badri Pharmaceuticals Private Limited (since 2007). The company operates in E-Commerce. Maharshi Badri Pharmaceuticals Private Limited reported revenue of ₹10.19 Cr (FY 2024).

DIN 01982715
Primary Designation Director
Industry E-Commerce
First Appointment 09 Apr 2007
Oldest Company Age 19 yrs
Largest company Maharshi Badri Pharmaceuticals Private Limited · ₹10.19 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director09 Apr 20072007₹10.19 Cr (FY 2024)Active

Board colleagues of Uday Singh

Directorship timeline

Open interactive timeline →
Maharshi Badri Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Uday Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Uday Singh

Uday Singh currently holds 1 directorship: Maharshi Badri Pharmaceuticals Private Limited (Director, since 09 Apr 2007, revenue ₹10.19 Cr (FY 2024)).

Uday Singh was first appointed on 09 Apr 2007 as Director at Maharshi Badri Pharmaceuticals Private Limited.

The current boards of Uday Singh's companies include Madan Lal (Maharshi Badri Pharmaceuticals Private Limited), Sanjay Kumawat (Maharshi Badri Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available